SEARCH

SEARCH BY CITATION

References

  • ADLER, M. & FILBERT, M.G. (1990). Role of butyrylcholinesterase in canine tracheal smooth muscle function. FEBS Lett., 267, 107110.
  • ATACK, J.R., YU, Q.S., SONCRANT, T.T., BROSSI, A. & RAPOPORT, S.I. (1989). Comparative inhibitory effects of various physostigmine analogs against acetyl- and butyrylcholinesterases. J. Pharmacol. Exp. Ther., 249, 194202.
  • BEHRA, M., COUSIN, X., BERTRAND, C., VONESCH, J.L., BIELLMANN, D., CHATONNET, A. & STRÄHLE, U. (2002). Acetylcholinesterase is required for neuronal and muscular development in the zebrafish embryo. Nat. Neurosci., 5, 111118.
  • BOWMAN, W.C., GIBB, A.J., HARVEY, A.L. & MARSHALL, I.G. (1986). Prejunctional actions of cholinoceptor agonist and antagonist and of anticholinesterase drugs. In Handbook of Experimental Pharmacology, Vol. 79, New neuromuscular Blocking Agents. ed. Kharkevich, D. pp. 141170. Berlin: Springer-Verlag.
  • BOWMAN, W.C., PRIOR, C. & MARSHALL, I.G. (1990). Presynaptic receptors in the neuromuscular junction. Ann. N.Y. Acad. Sci., 604, 6981.
  • BRAGA, M.F., ROWAN, E.G., HARVEY, A.L. & BOWMAN, W.C. (1993). Prejunctional action of neostigmine on mouse neuromuscular preparations. Br. J. Anaesth., 70, 405410.
  • BERMAN, H.A., DECKER, M.M. & JO, S. (1987). Reciprocal regulation of acetylcholinesterase and butyrylcholinesterase in mammalian skeletal muscle. Dev. Biol., 120, 154161.
  • CAULFIELD, M.P. & BIRDSALL, N.M.J. (1998). Classification of muscarine acetylcholine receptors. Pharmacol. Rev., 50, 279290.
  • CHANG, C.C., HUANG, C.Y. & HONG, S.J. (1990). Organic calcium channel antagonists provoke acetylcholine receptor autodesensitization on train stimulation of motor nerve. Neuroscience, 38, 731742.
  • CHATONNET, A. & LOCKRIDGE, O. (1989). Comparison of butyrylcholinesterase and acetylcholinesterase. Biochem. J., 260, 625634.
  • DUNCAN, C.J. & PUBLICOVER, S.J. (1979). Inhibitory effects of cholinergic agents on the release of transmitter at the frog neuromuscular junction. J. Physiol., 294, 91103.
  • DUYSEN, E.G., STRIBLEY, J.A., FRY, D.L., HINRICHS, S.H. & LOCKRIDGE, O. (2002). Rescue of the acetylcholinesterase knockout mouse by feeding a liquid diet; phenotype of the adult acetylcholinesterase deficient mouse. Dev. Brain Res., 137, 4354.
  • ELLMAN, G.L., COURTNEY, D.K., ANDRES, V. & FEATHERSTONE, R.M. (1961). A new and rapid colorimentric determination of acetylcholinesterase activity. Biochem. Pharmacol., 7, 8895.
  • FELTZ, A. & TRAUTMANN, A. (1980). Interaction between nerve-related acetylcholine and bath applied agonists at the frog end-plate. J. Physiol., 299, 533552.
  • FENG, G., KREJCI, E., MOLGÓ, J., CUNNINGHAM, J.M., MASSOULIÉ, J. & SANES, J.R. (1999). Genetic analysis of collagen Q: roles in acetylcholinesterase and butyrylcholinesterase assembly and in synaptic structure and function. J. Cell Biol., 144, 13491360.
  • GAUTRON, J. (1974). Cytochimie ultrastructurale des acétyl-cholinestérases. J. Microscopie., 21, 259264.
  • JOLKKONEN, M., VAN GIERSBERGEN, P.L., HELLMAN, U., WERNSTEDT, C. & KARLSSON, E. (1994). A toxin from the green mamba Dendroaspis angusticeps: amino acid sequence and selectivity for muscarinic m4 receptors. FEBS Lett., 352, 9194.
  • KATZ, B. & MILEDI, R. (1973). Binding of acetylcholine to receptors and its removal from the synaptic cleft. J. Physiol., 231, 549574.
  • KOELLE, G.B. (1950). The histochemical differentiation of types of cholinesterases and their localization in tissues of the cat. J. Pharmacol. Exp. Ther., 100, 158179.
  • KOELLE, G.B. & HORN, R.S. (1968). Acetyl disulfide, (CH3COS)2, a major active component in the thiolacetic acid histochemical method for acetylcholinesterase. J. Histochem. Cytochem., 16, 743753.
  • LAYER, P.G. & WILLBOLD, E. (1995). Novel functions of cholinesterases in development, physiology and disease. Prog. Histochem. Cytochem., 29, 194.
  • LI, B., STRIBLEY, J.A., TICU, A., XIE, W., SCHOPFER, L.M., HAMMOND, P., BRIMIJOIN, S., HINRICHS, S.H. & LOCKRIDGE, O. (2000). Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse. J. Neurochem., 75, 13201331.
  • LISTE, I., BERNARD, V. & BLOCK, B. (2002). Acute and chronic acetylcholinesterase inhibition regulates in vivo the localization and abundance of muscarinic receptors m2 and m4 at the cell surface and in the cytoplasm of striatal neurons. Mol. Cell. Neurosci., 20, 244256.
  • MASELLI, R.A. & SOLIVEN, B.C. (1991). Analysis of the organophosphate-induced electromyographic response to repetitive nerve stimulation; paradoxical response to edrophonium and D-tubocurarine. Muscle Nerve, 14, 11821188.
  • MASSOULIÉ, J., PEZZEMENTI, L., BON, S., KREJCI, E. & VALLETTE, F.M. (1993). Molecular and cellular biology of cholinesterases. Prog. Neurobiol., 41, 3191.
  • MCLACHLAN, E.M. & MARTIN, A.R. (1981). Non-linear summation of endplate potentials in the frog and mouse. J. Physiol., 311, 307324.
  • MINIC, J., MOLGÓ, J., KARLSSON, E. & KREJCI, E. (2001). Muscarinic receptors and the regulation of acetylcholine release at the mouse neuromuscular junction. J. Physiol., 536 (Suppl.): P125.
  • MINIC, J., MOLGÓ, J., KARLSSON, E. & KREJCI, E. (2002). Regulation of acetylcholine release by muscarinic receptors at the mouse neuromuscular junction depends on the activity of acetylcholinesterase. Eur. J. Neurosci., 15, 439448.
  • MOLGÓ, J. & THESLEFF, S. (1982). 4-aminoquinoline-induced ‘giant’ miniature endplate potentials at mammalian neuromuscular junctions. Proc. R. Soc. Lond. B Biol. Sci., 214, 229244.
  • NOREL, X., ANGRISANI, M., LABAT, C., GORENNE, I., DULMET, E., ROSSI, F. & BRINK, C. (1993). Degradation of acetylcholine in human airways: role of butyrylcholinesterase. Br. J. Pharmacol., 108, 914919.
  • OHNO, K., ENGEL, A.G., BRENGMAN, J.M., SHEN, X.M., HEIDENREICH, F., VINCENT, A., MILONE, M., TAN, E., DEMIRICI, M., WALSH, P., NAKANO, S. & AKIGUCHI, I. (2000). The spectrum of mutations causing end-plate acetylcholinesterase deficiency. Ann. Neurol., 47, 162170.
  • PRIMO-PARMO, S.L., BARTELS, C.F., WIERSEMA, B., VAN DER SPEK, A.F., INNIS, J.W. & LA, DU, B.N. (1996). Characterization of 12 silent alleles of the human butyrylcholinesterase (BCHE) gene. Am. J. Hum. Genet., 58, 5264.
  • SANTOS, M.D., ALKONDON, M., PEREIRA, E.F., ARACAVA, Y., EISENBERG, H.M., MAELICKE, A. & ALBUQUERQUE, E.X. (2002). The nicotinic allosteric potentiating ligand galantamine facilitates synaptic transmission in the mammalian central nervous system. Mol. Pharmacol., 61, 12221234.
  • SILMAN, I., DI GIAMBERERDINO, L., LYLES, L. & COURAUD, E.A. (1979). Parallel regulation of acetylcholinesterase and pseudocholinesterase in normal, denervated and dystrophic chicken skeletal muscle. Nature, 280, 160162.
  • TAYLOR, P. (1991). The cholinesterases. J. Biol. Chem., 266, 40254028.
  • TIAN, L., PRIOR, C., DEMPSTER, J. & MARSHALL, I.G. (1994). Nicotinic antagonist-produced frequency-dependent changes in acetylcholine release from rat motor nerve terminals. J. Physiol., 476, 517529.
  • THESLEFF, S., SELLIN, L.C. & TAGERUD, S. (1990). Tetrahydroaminoacridine (tacrine) stimulates neurosection at mammalian motor endplates. Br. J. Pharmacol., 100, 487490.
  • VAN DER KLOOT, W. & MOLGÓ, J. (1994). Quantal acetylcholine release at the vertebrate neuromuscular junction. Physiol. Rev., 74, 899991.
  • VIGNY, M., BON, S., MASSOULIÉ, J. & LETERRIER, F. (1978). Active-site catalytic efficiency of acetylcholinesterase molecular forms in Electrophorus, torpedo, rat and chicken. Eur. J. Biochem., 85, 317323.
  • WALCH, L., TAISNER, C., GASCARD, J.P., NASHASHIBI, N., BRINK, C. & NOREL, X. (1997). Cholinesterase activity in human pulmonary arteries and veins. Br. J. Pharmacol., 121, 986990.
  • XIE, W., STRIBLEY, J.A., CHATONNET, A., WILDER, P.J., RIZZINO, A., MCCOMB, R.D., TAYLOR, P., HINRICHS, S.H. & LOCKRIDGE, O. (2000). Postnatal developmental delay and supersensitivity to organophosphate in gene-targeted mice lacking acetylcholinesterase. J. Pharmacol. Exp. Ther., 293, 896902.